| Original language | English |
|---|---|
| Pages (from-to) | S356-S356 |
| Journal | CLINICAL LYMPHOMA MYELOMA & LEUKEMIA |
| Volume | 22 |
| Publication status | Published - 2022 |
MINDway: A Phase Ib/II Dose Optimization Study to Assess Safety and Pharmacokinetics of Tafasitamab plus Lenalidomide in Patients With Relapsed/Refractory Diffuse Large B-Cell Lymphoma
Richard Greil, K Kopeckova, L Arcaini, A Amin, K de Graaf, AM Jegg
Research output: Contribution to journal › Abstract (Journal) › peer-review